Skip to main content

Amy L Hartman

NIH Rank #487
  • Top 5% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12006449Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$8.1M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#487
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Amy L Hartman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Amy L Hartman as a PI. Multi-PI records show the full award amount for context.

  • 1U19AI181984-01U19
    Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP
    $5.2M
    award amount
  • 5R01AI169850-02R01
    Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
    $767.4K
    award amount
  • 5R01AI178378-02R01
    Mechanisms of Neuronal Infection by Prototype Emerging Bunyaviruses
    $757.6K
    award amount
  • 5R01AI161765-04R01
    Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
    $735.3K
    award amount
  • 5R01AI150792-04R01
    Live-attenuated Rift Valley fever vaccines: comparative mechanisms of trans-placental transmission and vaccine efficacy for developing fetuses
    $634.2K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Amy L Hartman as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #487
  7. 2024
    Entered Top 25% Nationally
    Ranked #487
  8. 2024
    Entered Top 10% Nationally
    Ranked #487
  9. 2024
    Entered Top 5% Nationally
    Ranked #487
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  12. 2025
    R01 Grant Holder